
Takako Taniguchi
Articles
-
4 weeks ago |
bloomberg.com | Lisa Du |Takako Taniguchi
Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world For Customers Bloomberg Anywhere Remote Login Software Updates Manage Products and Account Information Support Americas+1 212 318 2000 EMEA+44 20 7330 7500 Asia Pacific+65 6212 1000 Company About Careers Inclusion at Bloomberg Tech at Bloomberg Philanthropy Sustainability Bloomberg London...
-
4 weeks ago |
news.bloomberglaw.com | Lisa Du |Takako Taniguchi
Ariake Capital, a $320-million Japanese hedge fund founded by former Goldman Sachs Group Inc. analyst Katsunori Tanaka, is poised to make a profit of about $55 million from selling one of its major regional bank holdings. The Tokyo-based fund is in talks to sell its roughly 20% stake in Chiba Kogyo Bank Ltd. for about ¥20 billion ($133 million) to rival Chiba Bank Ltd., according to people familiar with the matter. Ariake acquired its stake for ¥11.7 billion, according to public filings.
-
4 weeks ago |
ca.finance.yahoo.com | Lisa Du |Takako Taniguchi
(Bloomberg) -- Ariake Capital, a $320-million Japanese hedge fund founded by former Goldman Sachs Group Inc. analyst Katsunori Tanaka, is poised to make a profit of about $55 million from selling one of its major regional bank holdings. • None They Built a Secret Apartment in a Mall. Now the Mall Is Dying. • None Why Did the Government Declare War on My Adorable Tiny Truck?
-
1 month ago |
japantimes.co.jp | Lisa Du |Takako Taniguchi
Blackstone is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private equity firms in the health needs of the nation’s aging population. The world’s largest alternative asset manager said it agreed to purchase 60% of Tokyo-based CMIC, a contract research organization, in a deal that values the company in the hundreds of millions of dollars.
-
1 month ago |
ca.finance.yahoo.com | Lisa Du |Takako Taniguchi
(Bloomberg) -- Blackstone Inc. is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private equity firms in the health needs of the nation’s aging population.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →